Do aromatic solvents increase glutathione utilization in the liver?

Exposure to aromatic solvents, such as benzene, toluene, and xylene (BTEX), triggers a well-defined metabolic cascade in the liver that significantly taxes the organ's primary antioxidant defenses. This process is particularly relevant when considering age-related changes in metabolic efficiency and antioxidant capacity.

Mechanistic pathway of biotransformation

The liver processes aromatic solvents through the cytochrome P450 (CYP450) enzyme system, specifically involving isoforms like CYP2E1 and CYP1B1. This biotransformation generates highly reactive electrophilic intermediates, such as epoxides and catechols. These intermediates are chemically unstable and prone to forming covalent adducts with cellular proteins and DNA. Additionally, the catalytic cycle of these enzymes inherently produces reactive oxygen species (ROS), including superoxide radicals and hydrogen peroxide, which directly induce systemic oxidative stress.

Glutathione utilization and depletion

To neutralize these reactive species, the liver relies heavily on glutathione (GSH), its most abundant endogenous antioxidant.

• Conjugation: Glutathione S-transferase (GST) enzymes use GSH to conjugate and neutralize reactive electrophilic intermediates for excretion.
• ROS Neutralization: Glutathione peroxidase (GSH-Px) utilizes GSH as a substrate to reduce hydrogen peroxide and lipid hydroperoxides, converting GSH into its oxidized form (GSSG). Evidence confirms that acute or chronic exposure to these solvents accelerates this utilization, often outpacing the liver's ability to regenerate GSH. This results in a shifted redox balance (increased GSSG/GSH ratio) and a measurable depletion of total cellular glutathione stores.

Clinical implications for liver health

When glutathione levels fall below critical thresholds, the liver's protection against oxidative damage is compromised. This lead to:

• Lipid Peroxidation: Unneutralized ROS attack the polyunsaturated fatty acids in hepatocyte membranes, measured by increases in markers like malondialdehyde (MDA).
• Hepatocellular Damage: The resulting membrane instability leads to the leakage of intracellular enzymes. Clinically, this is often observed as an elevation in alanine aminotransferase (ALT) levels, signifying cellular injury or necrosis.

Bottom line

The biotransformation of aromatic solvents creates a significant metabolic burden by generating reactive intermediates and oxidative stress. This process directly increases the utilization and eventual depletion of glutathione in the liver, which can lead to measurable hepatocellular damage and impaired detoxification capacity.